Digoxin: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
== Adult Dosing == | == Adult Dosing == | ||
*Loading dose = 0.25 mg IV q2hr until effect (max total = 1.5 mg | *Loading dose = 0.25 mg IV q2hr until effect (max total = 1.5 mg) | ||
== Contraindications == | == Contraindications == | ||
| Line 15: | Line 15: | ||
**Indirect vagal stimulator | **Indirect vagal stimulator | ||
== Adverse Drug | == Adverse Drug Reactions== | ||
*GI | *GI: N/V, diarrhea, abd pain | ||
*CV | *CV: Bradycardia, SA/AV block, ventr arrhythmias | ||
== Kinetics == | == Kinetics == | ||
Onset of action = 1.5-4hr (IV) | *Onset of action = 1.5-4hr (IV) | ||
==See Also== | ==See Also== | ||
Revision as of 17:33, 27 May 2012
Adult Dosing
- Loading dose = 0.25 mg IV q2hr until effect (max total = 1.5 mg)
Contraindications
- WPW
- Increases conduction velocity in atrial tissue
Indications
- RVR control in a-fib/flutter, PSVT
Mechanism of Action
- Inhibits NaK pump
- Positive inotropy
- Negative chronotropy/dromotropy
- Indirect vagal stimulator
Adverse Drug Reactions
- GI: N/V, diarrhea, abd pain
- CV: Bradycardia, SA/AV block, ventr arrhythmias
Kinetics
- Onset of action = 1.5-4hr (IV)